Clinical Trials Browser

Anemia, Refractory, with Excess of Blasts, Lymphoma, Hematologic Neoplasms

NCT03304678 2026-02-18

Discovery of Sirolimus Sensitive Biomarkers in Blood

Phase 2 Completed

33 enrolled 6 charts

Lymphangioleiomyomatosis

NCT01625351 2026-02-06

A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

Phase 1 Completed

23 enrolled

CNSDermatologicGastrointestinalGenitourinaryLymphoidSarcoma

Carcinoma, Renal Cell, Digestive System Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Melanoma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Adenocarcinoma, Clear Cell, Rhabdoid Tumor

NCT00975819 2026-01-06

Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies

Phase 2 Completed

61 enrolled 7 charts

Classical hematology

Tufted angioma, Lymphangioma, Thrombocytopenia

NCT01282697 2025-12-22

RAPIRI

Phase 1 Completed

42 enrolled

Other solid neoplasm

Refractory Solid Tumors in Children

Clinical Trials

Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies

Discovery of Sirolimus Sensitive Biomarkers in Blood

A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies

RAPIRI